The global AI Cardiovascular Screening System market was valued at US$ 569 million in 2025 and is anticipated to reach US$ 2649 million by 2032, at a CAGR of 24.5% from 2026 to 2032.

AI Cardiovascular Screening System Market

AI Cardiovascular Screening Systems are artificial intelligence–enabled solutions designed to support the early identification and risk stratification of cardiovascular diseases through non-invasive imaging and physiological data analysis. Unlike diagnostic systems used for definitive clinical confirmation, these systems focus on screening and triage, aiming to detect potential abnormalities at an early stage and prioritize patients for further evaluation. Typical inputs include echocardiography, vascular ultrasound, ECG, blood pressure data, and increasingly multimodal datasets. AI models automate tasks such as view recognition, automated measurements (e.g., chamber size, ejection fraction surrogates), abnormal pattern detection, and population-level risk scoring. These systems are widely applied in outpatient clinics, health check-up centers, primary care, and community screening programs, where efficiency, consistency, and scalability are critical.

From a multi-dimensional classification perspective, the market can be parameterized by screening modality (cardiac ultrasound–based, vascular ultrasound–based, ECG-based, or multimodal screening), target population (general population screening, high-risk groups such as hypertension or diabetes patients, occupational or elderly screening), AI functional scope (automated measurements, abnormality flagging, risk stratification, workflow triage), and deployment model (on-device embedded systems, hybrid edge–cloud platforms, or centralized cloud screening services). Regulatory positioning also differentiates solutions into research or wellness-oriented screening tools versus clinically validated screening systems cleared for medical use.

The value chain starts upstream with imaging device manufacturers, sensor and semiconductor suppliers, and data infrastructure providers. Midstream players include AI algorithm developers, cardiovascular software vendors, and system integrators responsible for embedding screening AI into existing ultrasound, ECG, or health IT platforms. Downstream customers consist of hospitals, outpatient cardiology clinics, primary care networks, health screening centers, and public health organizations. Partnerships with device OEMs and healthcare providers are particularly important, as screening systems must integrate smoothly into high-throughput workflows and existing information systems.

From an economic perspective, AI cardiovascular screening systems benefit from a software-heavy cost structure, with R&D, data annotation, clinical validation, and regulatory compliance representing the largest fixed costs. Once deployed at scale, incremental screening costs are relatively low, supporting favorable gross margins compared with traditional hardware-centric solutions. Market trends point toward rapid growth driven by aging populations, rising cardiovascular disease prevalence, expansion of preventive healthcare, and increasing adoption of AI-enabled point-of-care screening. Future developments are expected to include broader multimodal screening platforms, deeper integration with population health management systems, and wider use in large-scale preventive and community-based screening programs.

This report delivers a comprehensive overview of the global AI Cardiovascular Screening System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Cardiovascular Screening System. The AI Cardiovascular Screening System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI Cardiovascular Screening System market comprehensively. Regional market sizes by Type, by Application, by Deployment & Integration Model, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI Cardiovascular Screening System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI Cardiovascular Screening System Market Report

Report Metric	Details
Report Name	AI Cardiovascular Screening System Market
Accounted market size in 2025	US$ 569 million
Forecasted market size in 2032	US$ 2649 million
CAGR	24.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Ultrasound-based Screening ECG-based Screening Multimodal Imaging Screening Non-imaging Signal-based Screening Hybrid Clinical Data Screening
Segment by Deployment & Integration Model	On-device / Embedded AI Solutions Hybrid Edge–Cloud AI Platforms AI Plug-ins for Existing Ultrasound Systems Others
Segment by AI Functional Depth	Scan Guidance & View Recognition Automated Measurement & Quantification Structural & Functional Abnormality Detection Disease Classification & Risk Stratification Others
Segment by Application	Medical Institutions Great Health Scene
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Philips, UltraSight, Us2.ai, Ultromics, Butterfly Network, Exo Imaging, Canon Medical, Mindray, Samsung Medison, Clarius Mobile Health, HEBIN, Demetics Medical Technology, Shukun Technology, Shenzhen Keya Medical Technology（）
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Deployment & Integration Model, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Cardiovascular Screening System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI Cardiovascular Screening System Market growing?

Ans: The AI Cardiovascular Screening System Market witnessing a CAGR of 24.5% during the forecast period 2026-2032.

What is the AI Cardiovascular Screening System Market size in 2032?

Ans: The AI Cardiovascular Screening System Market size in 2032 will be US$ 2649 million.

Who are the main players in the AI Cardiovascular Screening System Market report?

Ans: The main players in the AI Cardiovascular Screening System Market are GE Healthcare, Philips, UltraSight, Us2.ai, Ultromics, Butterfly Network, Exo Imaging, Canon Medical, Mindray, Samsung Medison, Clarius Mobile Health, HEBIN, Demetics Medical Technology, Shukun Technology, Shenzhen Keya Medical Technology（）

What are the Application segmentation covered in the AI Cardiovascular Screening System Market report?

Ans: The Applications covered in the AI Cardiovascular Screening System Market report are Medical Institutions, Great Health Scene

What are the Type segmentation covered in the AI Cardiovascular Screening System Market report?

Ans: The Types covered in the AI Cardiovascular Screening System Market report are Ultrasound-based Screening, ECG-based Screening, Multimodal Imaging Screening, Non-imaging Signal-based Screening, Hybrid Clinical Data Screening

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Cardiovascular Screening System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Ultrasound-based Screening

1.2.3 ECG-based Screening

1.2.4 Multimodal Imaging Screening

1.2.5 Non-imaging Signal-based Screening

1.2.6 Hybrid Clinical Data Screening

1.3 Market by Deployment & Integration Model

1.3.1 Global AI Cardiovascular Screening System Market Size Growth Rate by Deployment & Integration Model: 2021 vs 2025 vs 2032

1.3.2 On-device / Embedded AI Solutions

1.3.3 Hybrid Edge–Cloud AI Platforms

1.3.4 AI Plug-ins for Existing Ultrasound Systems

1.3.5 Others

1.4 Market by AI Functional Depth

1.4.1 Global AI Cardiovascular Screening System Market Size Growth Rate by AI Functional Depth: 2021 vs 2025 vs 2032

1.4.2 Scan Guidance & View Recognition

1.4.3 Automated Measurement & Quantification

1.4.4 Structural & Functional Abnormality Detection

1.4.5 Disease Classification & Risk Stratification

1.4.6 Others

1.5 Market by Application

1.5.1 Global AI Cardiovascular Screening System Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Medical Institutions

1.5.3 Great Health Scene

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global AI Cardiovascular Screening System Market Perspective (2021–2032)

2.2 Global AI Cardiovascular Screening System Growth Trends by Region

2.2.1 Global AI Cardiovascular Screening System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI Cardiovascular Screening System Historic Market Size by Region (2021–2026)

2.2.3 AI Cardiovascular Screening System Forecasted Market Size by Region (2027–2032)

2.3 AI Cardiovascular Screening System Market Dynamics

2.3.1 AI Cardiovascular Screening System Industry Trends

2.3.2 AI Cardiovascular Screening System Market Drivers

2.3.3 AI Cardiovascular Screening System Market Challenges

2.3.4 AI Cardiovascular Screening System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Cardiovascular Screening System Players by Revenue

3.1.1 Global Top AI Cardiovascular Screening System Players by Revenue (2021–2026)

3.1.2 Global AI Cardiovascular Screening System Revenue Market Share by Players (2021–2026)

3.2 Global Top AI Cardiovascular Screening System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI Cardiovascular Screening System Revenue

3.4 Global AI Cardiovascular Screening System Market Concentration Ratio

3.4.1 Global AI Cardiovascular Screening System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Cardiovascular Screening System Revenue in 2025

3.5 Global Key Players of AI Cardiovascular Screening System Head Offices and Areas Served

3.6 Global Key Players of AI Cardiovascular Screening System, Products and Applications

3.7 Global Key Players of AI Cardiovascular Screening System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI Cardiovascular Screening System Breakdown Data by Type

4.1 Global AI Cardiovascular Screening System Historic Market Size by Type (2021–2026)

4.2 Global AI Cardiovascular Screening System Forecasted Market Size by Type (2027–2032)

5 AI Cardiovascular Screening System Breakdown Data by Application

5.1 Global AI Cardiovascular Screening System Historic Market Size by Application (2021–2026)

5.2 Global AI Cardiovascular Screening System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI Cardiovascular Screening System Market Size (2021–2032)

6.2 North America AI Cardiovascular Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI Cardiovascular Screening System Market Size by Country (2021–2026)

6.4 North America AI Cardiovascular Screening System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Cardiovascular Screening System Market Size (2021–2032)

7.2 Europe AI Cardiovascular Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI Cardiovascular Screening System Market Size by Country (2021–2026)

7.4 Europe AI Cardiovascular Screening System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI Cardiovascular Screening System Market Size (2021–2032)

8.2 Asia-Pacific AI Cardiovascular Screening System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI Cardiovascular Screening System Market Size by Region (2021–2026)

8.4 Asia-Pacific AI Cardiovascular Screening System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI Cardiovascular Screening System Market Size (2021–2032)

9.2 Latin America AI Cardiovascular Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI Cardiovascular Screening System Market Size by Country (2021–2026)

9.4 Latin America AI Cardiovascular Screening System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Cardiovascular Screening System Market Size (2021–2032)

10.2 Middle East & Africa AI Cardiovascular Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI Cardiovascular Screening System Market Size by Country (2021–2026)

10.4 Middle East & Africa AI Cardiovascular Screening System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Details

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare AI Cardiovascular Screening System Introduction

11.1.4 GE Healthcare Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.1.5 GE Healthcare Recent Development

11.2 Philips

11.2.1 Philips Company Details

11.2.2 Philips Business Overview

11.2.3 Philips AI Cardiovascular Screening System Introduction

11.2.4 Philips Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.2.5 Philips Recent Development

11.3 UltraSight

11.3.1 UltraSight Company Details

11.3.2 UltraSight Business Overview

11.3.3 UltraSight AI Cardiovascular Screening System Introduction

11.3.4 UltraSight Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.3.5 UltraSight Recent Development

11.4 Us2.ai

11.4.1 Us2.ai Company Details

11.4.2 Us2.ai Business Overview

11.4.3 Us2.ai AI Cardiovascular Screening System Introduction

11.4.4 Us2.ai Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.4.5 Us2.ai Recent Development

11.5 Ultromics

11.5.1 Ultromics Company Details

11.5.2 Ultromics Business Overview

11.5.3 Ultromics AI Cardiovascular Screening System Introduction

11.5.4 Ultromics Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.5.5 Ultromics Recent Development

11.6 Butterfly Network

11.6.1 Butterfly Network Company Details

11.6.2 Butterfly Network Business Overview

11.6.3 Butterfly Network AI Cardiovascular Screening System Introduction

11.6.4 Butterfly Network Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.6.5 Butterfly Network Recent Development

11.7 Exo Imaging

11.7.1 Exo Imaging Company Details

11.7.2 Exo Imaging Business Overview

11.7.3 Exo Imaging AI Cardiovascular Screening System Introduction

11.7.4 Exo Imaging Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.7.5 Exo Imaging Recent Development

11.8 Canon Medical

11.8.1 Canon Medical Company Details

11.8.2 Canon Medical Business Overview

11.8.3 Canon Medical AI Cardiovascular Screening System Introduction

11.8.4 Canon Medical Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.8.5 Canon Medical Recent Development

11.9 Mindray

11.9.1 Mindray Company Details

11.9.2 Mindray Business Overview

11.9.3 Mindray AI Cardiovascular Screening System Introduction

11.9.4 Mindray Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.9.5 Mindray Recent Development

11.10 Samsung Medison

11.10.1 Samsung Medison Company Details

11.10.2 Samsung Medison Business Overview

11.10.3 Samsung Medison AI Cardiovascular Screening System Introduction

11.10.4 Samsung Medison Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.10.5 Samsung Medison Recent Development

11.11 Clarius Mobile Health

11.11.1 Clarius Mobile Health Company Details

11.11.2 Clarius Mobile Health Business Overview

11.11.3 Clarius Mobile Health AI Cardiovascular Screening System Introduction

11.11.4 Clarius Mobile Health Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.11.5 Clarius Mobile Health Recent Development

11.12 HEBIN

11.12.1 HEBIN Company Details

11.12.2 HEBIN Business Overview

11.12.3 HEBIN AI Cardiovascular Screening System Introduction

11.12.4 HEBIN Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.12.5 HEBIN Recent Development

11.13 Demetics Medical Technology

11.13.1 Demetics Medical Technology Company Details

11.13.2 Demetics Medical Technology Business Overview

11.13.3 Demetics Medical Technology AI Cardiovascular Screening System Introduction

11.13.4 Demetics Medical Technology Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.13.5 Demetics Medical Technology Recent Development

11.14 Shukun Technology

11.14.1 Shukun Technology Company Details

11.14.2 Shukun Technology Business Overview

11.14.3 Shukun Technology AI Cardiovascular Screening System Introduction

11.14.4 Shukun Technology Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.14.5 Shukun Technology Recent Development

11.15 Shenzhen Keya Medical Technology（）

11.15.1 Shenzhen Keya Medical Technology（） Company Details

11.15.2 Shenzhen Keya Medical Technology（） Business Overview

11.15.3 Shenzhen Keya Medical Technology（） AI Cardiovascular Screening System Introduction

11.15.4 Shenzhen Keya Medical Technology（） Revenue in AI Cardiovascular Screening System Business (2021–2026)

11.15.5 Shenzhen Keya Medical Technology（） Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Shukun Technology

Shenzhen Keya Medical Technology

Clarius Mobile Health

HEBIN

Demetics Medical Technology

List of Tables

Table 1. Global AI Cardiovascular Screening System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Ultrasound-based Screening

Table 3. Key Players of ECG-based Screening

Table 4. Key Players of Multimodal Imaging Screening

Table 5. Key Players of Non-imaging Signal-based Screening

Table 6. Key Players of Hybrid Clinical Data Screening

Table 7. Global AI Cardiovascular Screening System Market Size Growth Rate by Deployment & Integration Model (US$ Million): 2021 vs 2025 vs 2032

Table 8. Key Players of On-device / Embedded AI Solutions

Table 9. Key Players of Hybrid Edge–Cloud AI Platforms

Table 10. Key Players of AI Plug-ins for Existing Ultrasound Systems

Table 11. Key Players of Others

Table 12. Global AI Cardiovascular Screening System Market Size Growth Rate by AI Functional Depth (US$ Million): 2021 vs 2025 vs 2032

Table 13. Key Players of Scan Guidance & View Recognition

Table 14. Key Players of Automated Measurement & Quantification

Table 15. Key Players of Structural & Functional Abnormality Detection

Table 16. Key Players of Disease Classification & Risk Stratification

Table 17. Key Players of Others

Table 18. Global AI Cardiovascular Screening System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global AI Cardiovascular Screening System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global AI Cardiovascular Screening System Market Size by Region (US$ Million), 2021–2026

Table 21. Global AI Cardiovascular Screening System Market Share by Region (2021–2026)

Table 22. Global AI Cardiovascular Screening System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 23. Global AI Cardiovascular Screening System Market Share by Region (2027–2032)

Table 24. AI Cardiovascular Screening System Market Trends

Table 25. AI Cardiovascular Screening System Market Drivers

Table 26. AI Cardiovascular Screening System Market Challenges

Table 27. AI Cardiovascular Screening System Market Restraints

Table 28. Global AI Cardiovascular Screening System Revenue by Players (US$ Million), 2021–2026

Table 29. Global AI Cardiovascular Screening System Market Share by Players (2021–2026)

Table 30. Global Top AI Cardiovascular Screening System Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Cardiovascular Screening System Revenue, 2025

Table 31. Ranking of Global Top AI Cardiovascular Screening System Companies by Revenue (US$ Million) in 2025

Table 32. Global 5 Largest Players Market Share by AI Cardiovascular Screening System Revenue (CR5 and HHI), 2021–2026

Table 33. Global Key Players of AI Cardiovascular Screening System, Headquarters and Area Served

Table 34. Global Key Players of AI Cardiovascular Screening System, Products and Applications

Table 35. Global Key Players of AI Cardiovascular Screening System, Date of General Availability (GA)

Table 36. Mergers and Acquisitions, Expansion Plans

Table 37. Global AI Cardiovascular Screening System Market Size by Type (US$ Million), 2021–2026

Table 38. Global AI Cardiovascular Screening System Revenue Market Share by Type (2021–2026)

Table 39. Global AI Cardiovascular Screening System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 40. Global AI Cardiovascular Screening System Revenue Market Share by Type (2027–2032)

Table 41. Global AI Cardiovascular Screening System Market Size by Application (US$ Million), 2021–2026

Table 42. Global AI Cardiovascular Screening System Revenue Market Share by Application (2021–2026)

Table 43. Global AI Cardiovascular Screening System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 44. Global AI Cardiovascular Screening System Revenue Market Share by Application (2027–2032)

Table 45. North America AI Cardiovascular Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. North America AI Cardiovascular Screening System Market Size by Country (US$ Million), 2021–2026

Table 47. North America AI Cardiovascular Screening System Market Size by Country (US$ Million), 2027–2032

Table 48. Europe AI Cardiovascular Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Europe AI Cardiovascular Screening System Market Size by Country (US$ Million), 2021–2026

Table 50. Europe AI Cardiovascular Screening System Market Size by Country (US$ Million), 2027–2032

Table 51. Asia-Pacific AI Cardiovascular Screening System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 52. Asia-Pacific AI Cardiovascular Screening System Market Size by Region (US$ Million), 2021–2026

Table 53. Asia-Pacific AI Cardiovascular Screening System Market Size by Region (US$ Million), 2027–2032

Table 54. Latin America AI Cardiovascular Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Latin America AI Cardiovascular Screening System Market Size by Country (US$ Million), 2021–2026

Table 56. Latin America AI Cardiovascular Screening System Market Size by Country (US$ Million), 2027–2032

Table 57. Middle East & Africa AI Cardiovascular Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 58. Middle East & Africa AI Cardiovascular Screening System Market Size by Country (US$ Million), 2021–2026

Table 59. Middle East & Africa AI Cardiovascular Screening System Market Size by Country (US$ Million), 2027–2032

Table 60. GE Healthcare Company Details

Table 61. GE Healthcare Business Overview

Table 62. GE Healthcare AI Cardiovascular Screening System Product

Table 63. GE Healthcare Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 64. GE Healthcare Recent Development

Table 65. Philips Company Details

Table 66. Philips Business Overview

Table 67. Philips AI Cardiovascular Screening System Product

Table 68. Philips Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 69. Philips Recent Development

Table 70. UltraSight Company Details

Table 71. UltraSight Business Overview

Table 72. UltraSight AI Cardiovascular Screening System Product

Table 73. UltraSight Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 74. UltraSight Recent Development

Table 75. Us2.ai Company Details

Table 76. Us2.ai Business Overview

Table 77. Us2.ai AI Cardiovascular Screening System Product

Table 78. Us2.ai Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 79. Us2.ai Recent Development

Table 80. Ultromics Company Details

Table 81. Ultromics Business Overview

Table 82. Ultromics AI Cardiovascular Screening System Product

Table 83. Ultromics Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 84. Ultromics Recent Development

Table 85. Butterfly Network Company Details

Table 86. Butterfly Network Business Overview

Table 87. Butterfly Network AI Cardiovascular Screening System Product

Table 88. Butterfly Network Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 89. Butterfly Network Recent Development

Table 90. Exo Imaging Company Details

Table 91. Exo Imaging Business Overview

Table 92. Exo Imaging AI Cardiovascular Screening System Product

Table 93. Exo Imaging Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 94. Exo Imaging Recent Development

Table 95. Canon Medical Company Details

Table 96. Canon Medical Business Overview

Table 97. Canon Medical AI Cardiovascular Screening System Product

Table 98. Canon Medical Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 99. Canon Medical Recent Development

Table 100. Mindray Company Details

Table 101. Mindray Business Overview

Table 102. Mindray AI Cardiovascular Screening System Product

Table 103. Mindray Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 104. Mindray Recent Development

Table 105. Samsung Medison Company Details

Table 106. Samsung Medison Business Overview

Table 107. Samsung Medison AI Cardiovascular Screening System Product

Table 108. Samsung Medison Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 109. Samsung Medison Recent Development

Table 110. Clarius Mobile Health Company Details

Table 111. Clarius Mobile Health Business Overview

Table 112. Clarius Mobile Health AI Cardiovascular Screening System Product

Table 113. Clarius Mobile Health Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 114. Clarius Mobile Health Recent Development

Table 115. HEBIN Company Details

Table 116. HEBIN Business Overview

Table 117. HEBIN AI Cardiovascular Screening System Product

Table 118. HEBIN Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 119. HEBIN Recent Development

Table 120. Demetics Medical Technology Company Details

Table 121. Demetics Medical Technology Business Overview

Table 122. Demetics Medical Technology AI Cardiovascular Screening System Product

Table 123. Demetics Medical Technology Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 124. Demetics Medical Technology Recent Development

Table 125. Shukun Technology Company Details

Table 126. Shukun Technology Business Overview

Table 127. Shukun Technology AI Cardiovascular Screening System Product

Table 128. Shukun Technology Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 129. Shukun Technology Recent Development

Table 130. Shenzhen Keya Medical Technology（） Company Details

Table 131. Shenzhen Keya Medical Technology（） Business Overview

Table 132. Shenzhen Keya Medical Technology（） AI Cardiovascular Screening System Product

Table 133. Shenzhen Keya Medical Technology（） Revenue in AI Cardiovascular Screening System Business (US$ Million), 2021–2026

Table 134. Shenzhen Keya Medical Technology（） Recent Development

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

Table 138. Authors List of This Report

List of Figures

Figure 1. AI Cardiovascular Screening System Picture

Figure 2. Global AI Cardiovascular Screening System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI Cardiovascular Screening System Market Share by Type: 2025 vs 2032

Figure 4. Ultrasound-based Screening Features

Figure 5. ECG-based Screening Features

Figure 6. Multimodal Imaging Screening Features

Figure 7. Non-imaging Signal-based Screening Features

Figure 8. Hybrid Clinical Data Screening Features

Figure 9. Global AI Cardiovascular Screening System Market Size Comparison by Deployment & Integration Model (US$ Million), 2021–2032

Figure 10. On-device / Embedded AI Solutions Features

Figure 11. Hybrid Edge–Cloud AI Platforms Features

Figure 12. AI Plug-ins for Existing Ultrasound Systems Features

Figure 13. Others Features

Figure 14. Global AI Cardiovascular Screening System Market Size Comparison by AI Functional Depth (US$ Million), 2021–2032

Figure 15. Scan Guidance & View Recognition Features

Figure 16. Automated Measurement & Quantification Features

Figure 17. Structural & Functional Abnormality Detection Features

Figure 18. Disease Classification & Risk Stratification Features

Figure 19. Others Features

Figure 20. Global AI Cardiovascular Screening System Market Size by Application (US$ Million), 2021–2032

Figure 21. Global AI Cardiovascular Screening System Market Share by Application: 2025 vs 2032

Figure 22. Medical Institutions Case Studies

Figure 23. Great Health Scene Case Studies

Figure 24. AI Cardiovascular Screening System Report Years Considered

Figure 25. Global AI Cardiovascular Screening System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 26. Global AI Cardiovascular Screening System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 27. Global AI Cardiovascular Screening System Market Share by Region: 2025 vs 2032

Figure 28. Global AI Cardiovascular Screening System Market Share by Players in 2025

Figure 29. Global AI Cardiovascular Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 30. The Top 10 and 5 Players Market Share by AI Cardiovascular Screening System Revenue in 2025

Figure 31. North America AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. North America AI Cardiovascular Screening System Market Share by Country (2021–2032)

Figure 33. United States AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Canada AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Europe AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Europe AI Cardiovascular Screening System Market Share by Country (2021–2032)

Figure 37. Germany AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. France AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. U.K. AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Italy AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Russia AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Ireland AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Asia-Pacific AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Asia-Pacific AI Cardiovascular Screening System Market Share by Region (2021–2032)

Figure 45. China AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Japan AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. South Korea AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Southeast Asia AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. India AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Australia & New Zealand AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Latin America AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Latin America AI Cardiovascular Screening System Market Share by Country (2021–2032)

Figure 53. Mexico AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Brazil AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Middle East & Africa AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Middle East & Africa AI Cardiovascular Screening System Market Share by Country (2021–2032)

Figure 57. Israel AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Saudi Arabia AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. UAE AI Cardiovascular Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. GE Healthcare Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 61. Philips Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 62. UltraSight Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 63. Us2.ai Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 64. Ultromics Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 65. Butterfly Network Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 66. Exo Imaging Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 67. Canon Medical Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 68. Mindray Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 69. Samsung Medison Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 70. Clarius Mobile Health Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 71. HEBIN Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 72. Demetics Medical Technology Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 73. Shukun Technology Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 74. Shenzhen Keya Medical Technology（） Revenue Growth Rate in AI Cardiovascular Screening System Business (2021–2026)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AI Lung Screening System Market Research Report 2024

Global AI Eye Screening System Market Research Report 2024

Global Cardiac AI assisted Diagnosis Market Research Report 2024

Global Artificial Intelligence Lung Screening System Market Research Report 2024

Global Cardiac AI assisted Diagnosis Solution Market Research Report 2024

Global AI Bone Screening System Market Research Report 2024

Global AI Implantable Cardiac Monitoring System Market Research Report 2024

Global Cardiac AI assisted Diagnosis Software Market Research Report 2024

Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Market Research Report 2024

Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Solution Market Research Report 2024

Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Software Market Research Report 2024

Global AI Head and Neck Screening System Market Research Report 2024

Global AI Medical Solutions Market Research Report 2025

Global Artificial Intelligence Bone Screening System Market Research Report 2024

Global AI Medical Product Market Research Report 2024

Global AI Surveillance System Market Research Report 2024

Global Medical and Health AI Product Market Research Report 2024

Global AI Medical Ultrasound System Market Research Report 2025

Global AI Medical Imaging Product Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions